Loading...
*  DNA vaccination
... such as those with AIDS). While killed vaccines do not have this risk, they cannot generate specific killer T cell responses ... Second generation vaccines were developed to reduce the risks from live vaccines. These are subunit vaccines, consisting of ... First generation vaccines are whole-organism vaccines - either live and weakened, or killed forms. Live, attenuated vaccines, ... A veterinary DNA vaccine to protect horses from West Nile virus has been approved. DNA vaccines elicit the best immune response ...
*  Pneumococcal conjugate vaccine
... such as those living with HIV/AIDS. The vaccine is, however, primarily developed for the U.S. and European epidemiological ... Pneumococcal conjugate vaccine (PCV) is a pneumococcal vaccine and a conjugate vaccine used to protect infants, young children ... Barocchi MA, Censini S, Rappuoli R (2007). "Vaccines in the era of genomics: the pneumococcal challenge". Vaccine. 25 (16): ... Johns Hopkins Bloomberg School of Public Health, International Vaccine Access Center (2013). "VIMS Report: Global vaccine ...
*  HIV vaccine
Global Alliance for Vaccines and Immunization (GAVI) International AIDS Vaccine Initiative (IAVI) AIDS Vaccine Advocacy ... HIV Vaccine Trials Network World AIDS Vaccine Day Sharp, Paul M.; Hahn, Beatrice H. (2011-09-01). "Origins of HIV and the AIDS ... 845 million was spent on AIDS vaccine research in 2011. Economic issues with developing an AIDS vaccine include the need for ... "Scientists see AIDS vaccine within reach after decades , Reuters". reuters.com. 2012. Retrieved 17 July 2012. "New HIV Vaccine ...
*  Malaria vaccine
Mullin, Emily (13 January 2014). "Scientists capture key protein structures that could aid malaria vaccine design". ... Malaria vaccine is a vaccine that is used to prevent malaria. The only approved vaccine as of 2015 is RTS,S. It requires four ... The vaccine was shown to be less effective for infants. Three doses of vaccine plus a booster reduced the risk of clinical ... The Type 2 vaccine could be thought of as a 'travellers' vaccine', aiming to prevent all cases of clinical symptoms in ...
*  AIDS Vaccine 200
Action Cycling Atlanta/AIDS Vaccine 200 AIDS Vaccine 200 AV 200 on YouTube AIDS Vaccine 200 - AV 200 on Facebook AIDS Vaccine ... through its Action Cycling 200 and AIDS Vaccine 200 rides has donated a total of $2,781,090 for AIDS vaccine research and AIDS- ... The majority of these funds ($557,000) has gone towards AIDS vaccine research at Emory Vaccine Center. The ride also ... 2.4 million to the Emory Vaccine Center, one of the world's leading vaccine research centers working to find an HIV vaccine. ...
*  World AIDS Vaccine Day
International AIDS Vaccine Initiative - India Website Kenya AIDS Vaccine Initiative (KAVI) The South Africa AIDS Vaccine ... World AIDS Vaccine Day, also known as HIV Vaccine Awareness Day, is observed annually on May 18. HIV vaccine advocates mark the ... preventive HIV vaccine can limit and eventually eliminate the threat of AIDS." The first World AIDS Vaccine Day was observed on ... South African AIDS Vaccine Initiative (SAAVI) World AIDS Day Bill Clinton's commencement speech at Morgan State University AIDS ...
*  AIDS Vaccine Bike Trek
... 2016 Charlottesville to Washington AIDS Vaccine Bike Trek 2017 Burlington to Portland AIDS Vaccine Bike ... Charity Treks, Inc has organized several AIDS Vaccine Bike Treks in North America: Montreal to Maine AIDS Vaccine Bike Trek ... Montreal to Boston AIDS Vaccine Bike Trek 2004, August 17-21 (Raised $118,150) Montreal to Boston AIDS Vaccine Bike Trek 2005, ... Montreal to Portland AIDS Vaccine Bike Trek 2007, August 14-18 (Raised $124,075) Burlington to Portland AIDS Vaccine Bike Trek ...
*  AIDS Vaccine Advocacy Coalition
... the International AIDS Vaccine Initiative, Until There's a Cure Foundation, Broadway Cares/Equity Fights AIDS, the Gill ... AVAC works to provide independent analysis, policy advocacy, public education and mobilisation to enhance AIDS vaccine research ... "AIDS Vaccine Advocacy Coalition(AVAC)". Archived from the original on 2011-07-20. ... and consumer-based organization working to accelerate ethical development and delivery of AIDS vaccines and other HIV ...
*  International AIDS Vaccine Initiative
... TechImpact @ Yale, 3(1), 1-2. Cohen, Jon (2009). Potent Antibodies Spark Vaccine Hopes. ... The International AIDS Vaccine Initiative (known as IAVI) is a global not-for-profit, public-private partnership working to ... It also partners with civil society organizations and other entities to advocate jointly for the development of AIDS vaccines, ... To address major obstacles in AIDS vaccine development, IAVI partners with HIV researchers from around the world. Its ...
*  Collaboration for AIDS Vaccine Discovery
The Collaboration for AIDS Vaccine Discovery (CAVD) is an international network of scientists, research organizations, and ... The CAVD was founded in 2006 when the Bill & Melinda Gates Foundation donated $287 million USD to promote HIV vaccine research ... The CAVD itself supports the Global HIV Vaccine Enterprise. The network comprises many individual institutions. "Gates ... Foundation Funds Major New Collaboration to Accelerate HIV Vaccine Development - DukeHealth.org". dukehealth.org. 19 July 2006 ...
*  South African AIDS Vaccine Initiative
The South African AIDS Vaccine Initiative or SAAVI is a South African organisation with the mission of coordinating the ... Faul, Michelle (20 June 2009). "South Africa launches AIDS vaccine trial but slashes research funding". washingtonexaminer.com ... SAAVI announced that it was testing a new HIV vaccine candidate but suspended all further vaccine development indefinitely due ... SAAVI frequently partners with the HIV Vaccine Trials Network.[citation needed] In June 2009, ...
*  Mucosal immunology
Bourinbaiar, Aldar S.; Metadilogkul, Orapun; Jirathitikal, Vichai (2003). "Mucosal AIDS Vaccines". Viral Immunology. 16 (4): ... the mucosal immune system is being investigated for use in vaccines for various afflictions, including AIDS and allergies. " ... "Recent progress in HIV vaccines inducing mucosal immune responses". AIDS (London, England). 28 (12): 1701-18. doi:10.1097/qad. ... Mucosal Immunity and Vaccines, August 2003 Pavot, V; Rochereau, N; Lawrence, P; Girard, MP; Genin, C; Verrier, B; Paul, S (31 ...
*  Raghavan Varadarajan
Merck have tested the a few vaccines and some of the other proposals are being tested by International AIDS Vaccine Initiative ... and International AIDS Vaccine Initiative for the development of HIV vaccines. He has also mentored a number of scholars in ... International AIDS Vaccine Initiative. May 2, 2007. Retrieved October 19, 2016. "Seminar by Prof. Raghavan Varadarajan". ... his team developed a number of immunogens which have been demonstrated to have positive effect as HIV-1 vaccines and he holds ...
*  Long-term nonprogressor
International AIDS Vaccine Initiative. [1] accessed Dec 2007. Archived October 9, 2006, at the Wayback Machine. Poropatich, ... AIDS. 20 (5): 685-9. doi:10.1097/01.aids.0000216368.23325.bc. PMID 16514298. Thorven M, Grahn A, Hedlund KO, Johansson H, ... "Mitochondrial DNA haplogroups influence AIDS progression". AIDS. 22 (18): 2429-2439. doi:10.1097/QAD.0b013e32831940bb. ISSN ... Without the symptoms of AIDS, many LTNP patients may not know they are infected. Genetic traits that confer greater resistance ...
*  Remune
The International AIDS Vaccine Research (IAVA) issued a report on "Whole Killed AIDS Vaccines" in 1999 reviewing a diverse ... IRBP) Remune is a therapeutic HIV/AIDS vaccine that has completed over 25 clinical studies to date and shows a robust mechanism ... doi:10.1046/j.1468-1293.2001.00051.x. IAVI Report on Whole Killed AIDS Vaccines. ... The vaccine, however, does not contain gp120 surface antigen as it falls off on fixation of HIV-1. As a result, only gp41 is ...
*  SAV001
The International AIDS Vaccine Research (IAVA) issued a report on "Whole Killed AIDS Vaccines" in 1999 reviewing a diverse ... Immune Response BioPharma, Inc A Killed-Virus Vaccine for HIV/AIDS IAVI Report on Whole Killed AIDS Vaccines Welcome to the ... Whole Killed AIDS Vaccines US Patent: HIV COMBINATION VACCINE AND PRIME BOOST Sumagen Canada Homepage Curocom Homepage Schulich ... The SAV001-H vaccine is considered as the first genetically modified version of the killed whole HIV-1 vaccine. According to Dr ...
*  Ian Gust
... particularly in the prevention of hepatitus and AIDS. Gust, Ian D.; Kahn, Patricia; Koff, Wayne C. (2007). AIDS Vaccine ... Gust's area of work is in the development of drugs and vaccines against viral diseases and he is best known for the development ... The most cited are: Gust, I.D. "Epidemiological patterns of hepatitis A in different parts of the world" (1992) Vaccine, 10 ( ... "Professor Ian Gust". Vaccine and Immunotherapy Technologies. Sir Mark Oliphant Conferences. 2008. Retrieved 11 April 2012. " ...
*  Becton Dickinson
"International AIDS Vaccine Initiative Press Release". Archived from the original on 2011-07-16. "Foundation for Innovative New ... International AIDS Vaccine Initiative, Foundation for Innovative New Diagnostics, Juvenile Diabetes Research Foundation, ... 1 million contribution to the International AIDS Vaccine Initiative (2002.) In 2003 and 2004, BD introduced several innovative ... This innovative product was used in a large-scale field test of the polio vaccine developed by Dr. Jonas Salk. One year later, ...
*  Medroxyprogesterone acetate
AVAC (January 27, 2015). "News from the HC-HIV front: it's raining meta (analyses)!". New York: AIDS Vaccine Advocacy Coalition ...
*  Hildegund C.J. Ertl
"Building a better vaccine Hildegund Ertl and her Philadelphia researchers pursue a new way to conquer the AIDS virus, threats ... human papilloma virus vaccines, rabies vaccine models, universal influenza vaccine, vaccines to Epstein-Barr virus, and using ... Her research is focused on developing vaccines for AIDS and various forms of cancer. Her lab is currently working on projects ... In interviews, Ertl has been cautious and critical when it comes to the development of vaccines for AIDS. Her research has ...
*  Zinc finger nuclease
AIDS vaccine- Washington, Seattle 2007, :P05-01. Wayengera, M (2007). "A Recombinant lactobacillus strain producing restriction ... It is also hoped that, when applied to non-HIV infected persons, this strategy could offer a genomic vaccine against HIV and ... Stone, D.; Kiem, H. P.; Jerome, K. R. (2013). "Targeted gene disruption to cure HIV". Curr Opin HIV AIDS. 8. Coakley, E.; ... Alkhatib, G (2009). "The biology of CCR5 and CXCR4". Current Opinion in HIV and AIDS. 4 (2): 96-103. doi:10.1097/coh. ...
*  Correlates of immunity/correlates of protection
International AIDS Vaccine Initiative HIV Vaccine Trials Network. ... The fact that the correlates of immunity/protection remain unclear is a significant barrier to HIV vaccine research. There is ... However, without knowing the correlates of immunity, scientists cannot know exactly what sort of immune response a vaccine ... suggesting that immunity and therefore a vaccine is possible. ... and the only method of assessing vaccine effectiveness will be ...
*  Scripps Research Institute
"Center for HIV/AIDS Vaccine Immunology & Immunogen Discovery". scripps.edu. "Scripps Center for Metabolomics and Mass ... The institute also incorporates the: Center for HIV/AIDS Vaccine Immunology & Immunogen Discovery Center for Integrative ...
*  Alan Bernstein
Newspaper Article". IAVI report : newsletter on international AIDS vaccine research. 12 (6): 18-21. PMID 20218020. Chabot, B.; ... Global HIV Vaccine Enterprise. VaccineEnterprise.org. McLaughlin Medal. Royal Society of Canada. Genetics Society of Canada ... Prior to his position at CIFAR, Bernstein was the inaugural executive director of the Global HIV Vaccine Enterprise, an ... Gewin, V. (2007). "Alan Bernstein, executive director, Global HIV Vaccine Enterprise, Seattle, Washington". Nature. 450 (7167 ...
*  United States Military HIV Research Program
dead link] McNeil Jr, Donald G. (2009-09-25). "For First Time, AIDS Vaccine Shows Some Success". New York Times. Retrieved 2009 ... MHRP scientists are also pursuing other global vaccine strategies, which include MVA vaccines developed by MHRP and NIAID ... In addition to vaccine development and testing, MHRP also conducts therapeutic research, tracks the HIV epidemic in active-duty ... MHRP is distinct from the Defense HIV/AIDS Prevention Program, which was instituted in the late 1990s to address the spread of ...
*  Cervical cancer
The vaccines are between 92% and 100% effective against HPV 16 and 18 up to at least 8 years. HPV vaccines are typically given ... Also, not only does it aid in the development of HPV, but also if the woman is already HPV-positive, she is at an even greater ... The vaccines have been shown to be effective for at least four to six years, and they are believed to be effective for longer; ... HPV vaccines protect against between two and seven high-risk strains of this family of viruses and may prevent up to 90% of ...
*  Mary Lou Clements-Mann
An Expert on AIDS Vaccines". The New York Times. Retrieved July 18, 2014. ... Mary Lou Clements-Mann was the longtime head of the Division of Vaccine Sciences at the Johns Hopkins Bloomberg School of ... She was a member of the US Centers for Disease Control Advisory Committee on the Children's Vaccine Initiative and the World ... Public Health, and is well known for her knowledge and work in HIV and AIDS. She died in the 1998 crash of Swissair Flight 111 ...